These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9619535)

  • 1. Acute insulin response to intravenous glucagon in polycystic ovary syndrome.
    Ciampelli M; Fulghesu AM; Murgia F; Guido M; Cucinelli F; Apa R; Caruso A; Lanzone A
    Hum Reprod; 1998 Apr; 13(4):847-51. PubMed ID: 9619535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid blockade effect on insulin beta-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus.
    Ciampelli M; Fulghesu AM; Guido M; Murgia F; Muzj G; Belosi C; Fortini A; Cento R; Lanzone A
    Horm Res; 1998; 49(6):263-8. PubMed ID: 9623517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in beta cell activity, hepatic insulin clearance and peripheral insulin sensitivity in women with polycystic ovary syndrome.
    Ciampelli M; Fulghesu AM; Cucinelli F; Pavone V; Caruso A; Mancuso S; Lanzone A
    Hum Reprod; 1997 Sep; 12(9):1897-901. PubMed ID: 9363702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth hormone response to growth hormone-releasing hormone is blunted in polycystic ovary syndrome: relationship with obesity and hyperinsulinaemia.
    Lanzone A; Villa P; Fulghesu AM; Pavone V; Caruso A; Mancuso S
    Hum Reprod; 1995 Jul; 10(7):1653-7. PubMed ID: 8582956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome.
    Svendsen PF; Nilas L; Nørgaard K; Jensen JE; Madsbad S
    Hum Reprod; 2008 Sep; 23(9):2113-21. PubMed ID: 18556679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome.
    Lanzone A; Fulghesu AM; Cucinelli F; Guido M; Pavone V; Caruso A; Mancuso S
    Hum Reprod; 1996 Nov; 11(11):2382-6. PubMed ID: 8981115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
    Sepilian V; Nagamani M
    J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Tapanainen JS
    Hum Reprod; 2000 Jun; 15(6):1266-74. PubMed ID: 10831553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia alters tumor necrosis factor-alpha release from mononuclear cells in women with polycystic ovary syndrome.
    González F; Minium J; Rote NS; Kirwan JP
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5336-42. PubMed ID: 15985479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia.
    Ciotta L; De Leo V; Galvani F; La Marca A; Cianci A
    Hum Reprod; 1999 Dec; 14(12):2951-8. PubMed ID: 10601077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.
    Sam S; Vellanki P; Yalamanchi SK; Bergman RN; Dunaif A
    Metabolism; 2017 Jun; 71():125-131. PubMed ID: 28521865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome.
    Mumm H; Altinok ML; Henriksen JE; Ravn P; Glintborg D; Andersen M
    Hum Reprod; 2016 May; 31(5):1105-12. PubMed ID: 27008892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.
    Dunaif A; Finegood DT
    J Clin Endocrinol Metab; 1996 Mar; 81(3):942-7. PubMed ID: 8772555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA; Lewy V; Danadian K; Saad R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activation of nuclear factor kappaB triggers inflammation and insulin resistance in polycystic ovary syndrome.
    González F; Rote NS; Minium J; Kirwan JP
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1508-12. PubMed ID: 16464947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen response to endogenous insulin secretion during the frequently sampled intravenous glucose tolerance test in normal and hyperandrogenic women.
    Falcone T; Finegood DT; Fantus IG; Morris D
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1653-7. PubMed ID: 2146285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.